A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
Public ClinicalTrials.gov record NCT06381583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Liquid Biopsy to Screen for Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma: the EMERALD Multi-center Study.
Study identification
- NCT ID
- NCT06381583
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- City of Hope Medical Center
- Other
- Enrollment
- 658 participants
Conditions and interventions
Conditions
- Barrett Adenocarcinoma
- Barrett Epithelium
- Barrett Esophagus
- Barrett Esophagus, Long-Segment
- Barrett's Esophagus With Dysplasia, Unspecified
- Barrett's Esophagus With Esophagitis
- Barrett's Esophagus Without Dysplasia
- Barretts Esophagus With Dysplasia
- Barretts Esophagus With High Grade Dysplasia
- Barretts Esophagus With Low Grade Dysplasia
- Esophageal Adenocarcinoma
- Esophageal Cancer
- Esophageal Cancer Stage
- Esophageal Dysplasia
- Esophageal Neoplasms
- Esophageal Neoplasms Malignant
- Esophagus Adenocarcinoma
- Esophagus Cancer
- Esophagus, Barrett
- Gastroesophageal Reflux
- Reflux Disease
Interventions
- EMERALD (Esophageal MicroRNAs for BaRRett's esophagus, Adenocarcinoma, and Dysplasia) Diagnostic Test
Diagnostic Test
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2023
- Primary completion
- Apr 23, 2024
- Completion
- Apr 23, 2024
- Last update posted
- May 9, 2024
2023 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06381583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2024 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06381583 live on ClinicalTrials.gov.